公开(公告)号：US20230285408A1

公开(公告)日：2023-09-14

申请号：US18318804

申请日：2023-05-17

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/28 ,  A61K9/00

CPC分类号： A61K31/55 ,  A61P25/28 ,  A61K9/0053

摘要： Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.

公开(公告)号：US11351179B1

公开(公告)日：2022-06-07

申请号：US17394898

申请日：2021-08-05

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/22 ,  A61P25/24 ,  A61K31/519

摘要： Pharmaceutical compositions comprising azelastine or a pharmaceutically acceptable salt of azelastine and folic acid or folate, and/or salts, metabolites, or derivatives thereof are disclosed. Methods of using the pharmaceutical compositions for treating patients suffering from one or more psychiatric disorders or symptoms, such as major depressive disorder, generalized anxiety disorder, panic disorder, agitation, social anxiety disorder, mild chronic depression, obsessive-compulsive disorder, premenstrual dysphoric disorder, seasonal affective disorder, dysthymia, bipolar disorder, posttraumatic stress disorder, sleep disorder related to anxiety, are also disclosed.

公开(公告)号：US20200323877A1

公开(公告)日：2020-10-15

申请号：US16884553

申请日：2020-05-27

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/5517 ,  A61K31/55 ,  A61K9/00 ,  A61P25/28

摘要： Pharmaceutical compositions containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease for symptoms of depression, anxiety, agitation, delusions, hallucination, irritability and sleeping disorder, are also disclosed.

公开(公告)号：US11690849B2

公开(公告)日：2023-07-04

申请号：US17459868

申请日：2021-08-27

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/28 ,  A61K9/00

CPC分类号： A61K31/55 ,  A61K9/0053 ,  A61P25/28

摘要： Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.

公开(公告)号：US11318144B2

公开(公告)日：2022-05-03

申请号：US16913927

申请日：2020-06-26

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61K31/714 ,  A61K9/00

摘要： Pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt of azelastine, and methylcobalamin are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease or Parkinson's disease are also disclosed.

公开(公告)号：US20200323870A1

公开(公告)日：2020-10-15

申请号：US16831330

申请日：2020-03-26

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/28 ,  A61K9/00

摘要： Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.

公开(公告)号：US11938139B2

公开(公告)日：2024-03-26

申请号：US16884459

申请日：2020-05-27

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/5517 ,  A61K9/00

CPC分类号： A61K31/5517 ,  A61K9/0053

摘要： Pharmaceutical compositions comprising azelastine or a pharmaceutically acceptable salt of azelastine and alprazolam are disclosed. Methods of using the pharmaceutical compositions for treating patients suffering from one or more psychiatric disorders such as major depressive disorder, generalized anxiety disorder, panic disorder, agitation, social anxiety disorder, mild chronic depression, obsessive-compulsive disorder, premenstrual dysphoric disorder, seasonal affective disorder, dysthymia, childhood enuresis, bipolar disorder, posttraumatic stress disorder, sleep disorder related to anxiety, are also disclosed.

公开(公告)号：US20220000882A1

公开(公告)日：2022-01-06

申请号：US17459868

申请日：2021-08-27

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/28 ,  A61K9/00

摘要： Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.

公开(公告)号：US20200323873A1

公开(公告)日：2020-10-15

申请号：US16913927

申请日：2020-06-26

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61K31/714

摘要： Pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt of azelastine, and methylcobalamin are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease or Parkinson's disease are also disclosed.

公开(公告)号：US20200323867A1

公开(公告)日：2020-10-15

申请号：US16382885

申请日：2019-04-12

申请人： LA PharmaTech Inc.

发明人： Jianmin Wang ,  Geping Cui

IPC分类号： A61K31/55 ,  A61P25/28 ,  A61P25/16

摘要： A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and memantine or a pharmaceutically acceptable salt of memantine is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.